Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Different angiogenic pathways in human cervical cancers

K Tokumo1, J Kodama, N Seki

  • 1Department of Obstetrics and Gynecology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama, 700, Japan.

Gynecologic Oncology
|February 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression.

Transplantation proceedings·2000
Same author

ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression.

Transplantation proceedings·2000
Same author

Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience.

Transplantation proceedings·2000
Same author

Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers.

International journal of oncology·2000
Same author

Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.

International journal of oncology·2000
Same author

Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice.

The Journal of pharmacy and pharmacology·2000

Vascular endothelial growth factor (VEGF) promotes angiogenesis in cervical cancers, while platelet-derived endothelial cell growth factor (PD-ECGF) expression differs by cancer type. Angiogenic pathways vary across cervical cancer subtypes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pathology

Background:

  • Cervical cancer angiogenesis is crucial for tumor growth and metastasis.
  • Understanding the roles of angiogenic factors like VEGF and PD-ECGF is vital for targeted therapies.

Purpose of the Study:

  • To investigate the association between VEGF and PD-ECGF expression and clinicopathological features in cervical cancers.
  • To evaluate the relationship between these factors and tumor angiogenesis.

Main Methods:

  • Immunohistochemical staining of VEGF and PD-ECGF in 73 cervical cancer specimens (stage Ib-IIb).
  • Assessment of microvessel density using factor VIII-related antigen immunostaining.
  • Correlation analysis between angiogenic factor expression, microvessel density, and cancer subtypes (squamous cell carcinoma, adenocarcinoma).

Related Experiment Videos

Main Results:

  • Adenocarcinomas showed significantly higher microvessel density and VEGF expression compared to squamous cell carcinomas.
  • Squamous cell carcinomas exhibited significantly higher PD-ECGF expression than adenocarcinomas and adenosquamous carcinomas.
  • An inverse relationship was observed between VEGF and PD-ECGF expression; VEGF correlated positively with microvessel density.

Conclusions:

  • VEGF expression is implicated in promoting angiogenesis in cervical cancers.
  • Distinct cervical cancer subtypes may utilize different angiogenic pathways.
  • Findings suggest potential for subtype-specific anti-angiogenic strategies.